← ANALYSTS · TIPRANKS
Lachlan Hanbury Brown · William Blair
Hits
35%
34 of 97 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−5.4%
Over a year after the rating, TipRanks’ measure
Our companies rated now
10
Buy / hold / sell: 9 / 1 / 0
Upside of the analyst’s targets
—
Average over 0 current targets, to the last price
The market’s answer to the ratings
—
No upgrade, downgrade or target change with a known move yet
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 5on TipRanks 10:55 | HROWIWMHarrow Health · $1.1B | Reiterated | Buy | — | — | −0.3%next day −1.3% · 5 days −5.2% | ↗ |
| Oct 2on TipRanks 10:15 | SRZNIWMSurrozen · $295M | Reiterated | Buy | — | — | −3.0%next day −1.3% · 5 days +0.1% | ↗ |
| Sep 30on TipRanks 12:55 | ZVRAIWMZevra Therapeutics · $610M | Reiterated | Buy | — | — | −3.1%next day −7.4% · 5 days −0.9% | ↗ |
| Sep 29on TipRanks 11:55 | QUREuniQure · $1.5B | Reiterated | Buy | — | — | −37.1%next day −1.2% · 5 days −7.9% | ↗ |
| Sep 28on TipRanks 16:35 | SRPTIWMSarepta Therapeutics · $1.9B | Reiterated | Hold | — | — | −0.7%next day −2.0% · 5 days −9.1% | ↗ |
| Sep 25on TipRanks 13:45 | OCULIWMOcular Therapeutix · $1.6B | Reiterated | Buy | — | — | −2.3%next day −19.9% · 5 days −27.7% | ↗ |
| Sep 24on TipRanks 10:55 | SRZNIWMSurrozen · $295M | Reiterated | Buy | — | — | +108.5%next day −12.8% · 5 days −10.5% | ↗ |
| Aug 20on TipRanks 10:55 | HROWIWMHarrow Health · $1.1B | Reiterated | Buy | — | — | +1.8%next day −3.0% · 5 days −9.5% | ↗ |
| Aug 14on TipRanks 05:25 | SPRYIWMARS Pharmaceuticals · $405M | Reiterated | Buy | — | — | −7.2%next day +10.9% · 5 days −1.2% | ↗ |
| Aug 12on TipRanks 11:05 | TARSIWMTarsus Pharmaceuticals · $3.5B | Reiterated | Buy | — | — | +0.5%next day −2.3% · 5 days +5.3% | ↗ |
| Aug 12on TipRanks 10:15 | LENZIWMLENZ Therapeutics · $112M | Reiterated | Buy | — | — | −3.5%next day −9.4% · 5 days −1.9% | ↗ |
| Aug 6on TipRanks 15:15 | VRDNIWMViridian Therapeutics · $2.2B | Reiterated | Buy | — | — | +7.0%next day +4.2% · 5 days −3.5% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗